Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cartilage matrix, particularly in joint tissue (articular cartilage), is a specialized form of connective tissue that covers the ends of bones in synovial joints. Its primary function is to provide a smooth, lubricated surface for articulation and to facilitate the transmission of loads with minimal friction. The matrix is avascular, meaning it lacks blood vessels, nerves, and lymphatics. The ECM forms the bulk of cartilage and consists mainly of water (~65–80% by weight), collagen fibers (primarily type II collagen), proteoglycans (notably aggrecan), non-collagenous proteins, glycoproteins, and other minor components. It is organized into distinct zones (Superficial, Middle, Deep, Calcified) with functional regions around chondrocytes (Pericellular, Territorial, Interterritorial). Damage or degeneration of articular cartilage leads directly to conditions like osteoarthritis. Because it is avascular, self-repair capacity is limited. Recent advances include using bioactive peptides that mimic extracellular matrix motifs or bind specifically to components like type II collagen/chondrogenic ligands.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage Matrix (Joint Tissue).